Before details of the NGIO IPO and pre-clinical tr
Post# of 36537
OTOH, you would have to be pretty obtuse to have missed the nuggets he has left the last couple of months. Of course, I see things in the dark that are not really there sometimes. Perhaps I am mistaken.